blank
blank

Patient Partner Compensation Guidelines

1:1
"Patient partner" is an overarching term that includes individuals with lived experience, including patients, caregivers, family, and friends.

This document outlines IG’s compensation guidelines for patients and caregivers who contribute their time and expertise to IG’s efforts (e.g., committees, working groups) or for patients and caregivers who are invited by IG to attend and participate in specific events (e.g., launch events, workshops, and meetings). These guidelines were developed for individuals who wish to be compensated, recognizing that not all individuals will wish to be. Payment for expenses (e.g., travel) are not considered to be compensation and are reimbursed separately.

These guidelines are meant to help start a conversation between IG and patient partners about compensation. IG values flexibility, equity, and inclusion in its approach to patient partner compensation.

Acces this publication
4in-solidarity-649713_1920

Year of publication

2026

Author

IRSC CIHR

You might also be interested in

Open Academy

Open Academy x ERDERA Schools return to Barcelona to strengthen rare disease research participation

From 25–28 May in Barcelona, the EURORDIS-led Open Academy x ERDERA Schools will bring patient advocates and early-career researchers together for four days of rare disease training, exchange and peer learning.
Captura de pantalla 2026-05-15 093018

NIHR Children and Young People Health Research Centre (NIHR HRC-PCH)

Children, Young People and Family Involvement and Engagement Strategy 2024-2029
joelfazhari-doctor-6989582_1920

Public Involvement in Research Impact Toolkit (PIRIT)

Public involvement positively shapes research. By sharing their time and personal experiences with researchers, members of the public can influence what research takes place, how it’s carried out, and how the results are shared.
stefan_schranz-crutches-538883_1920

The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?

As public involvement in the design, conduct and dissemination of health research has become an expected norm and firmly enshrined in policy, interest in measuring its impact has also grown. Despite a drive to assess the impact of public involvement, and a growing body of studies attempting to do just this, a number of questions have been largely ignored.

ERDERA's

search form